Literature DB >> 6501932

A whole-blood lymphocyte stimulation test for the diagnosis of human tularemia.

H Syrjälä, E Herva, J Ilonen, K Saukkonen, A Salminen.   

Abstract

A whole-blood lymphocyte stimulation test was used in the diagnosis of 200 cases of tularemia. Ninety-one of the patients involved had ulceroglandular infection, 81 had pulmonary infection, 13 had glandular infection, four had oropharyngeal infection, and one had oculoglandular infection. The clinical picture was obscure in the remaining 10 cases. Results of the lymphocyte stimulation test became positive in 21.3% of cases during the first week, when an agglutinating titer of greater than or equal to 1:80 was found in 2.1% of patients. During the second week, these proportions were 96.8% and 53.3%, respectively. In only one patient with tularemia (0.5%) did the stimulation test result remain negative, and only one (0.5%) of the 211 control patients had a positive result in the first test. The development of cell-mediated immunity followed the same pattern in patients with ulceroglandular tularemia as in those with pulmonary tularemia.

Entities:  

Mesh:

Year:  1984        PMID: 6501932     DOI: 10.1093/infdis/150.6.912

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  The proportion of circulating gammadelta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year.

Authors:  M Kroca; A Tärnvik; A Sjöstedt
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

Authors:  A Tärnvik; M Eriksson; G Sandström; A Sjöstedt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

3.  Kinetics of the immune response associated with tularemia: comparison of an enzyme-linked immunosorbent assay, a tube agglutination test, and a novel whole-blood lymphocyte stimulation test.

Authors:  Henrik Eliasson; Per Olcén; Anders Sjöstedt; Margareta Jurstrand; Erik Bäck; Sören Andersson
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

4.  Cell-mediated and humoral immune responses after vaccination of human volunteers with the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; K T McKee; G Sandstrom; L L Pratt; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

5.  Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination.

Authors:  R Karttunen; G Andersson; H P Ekre; K Juutinen; H M Surcel; H Syrjälä; E Herva
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

6.  Guillain-Barré syndrome and tularemia pleuritis with high adenosine deaminase activity in pleural fluid.

Authors:  H Syrjälä; P Koskela; P Kujala; V Myllylä
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

7.  Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.

Authors:  Y Poquet; M Kroca; F Halary; S Stenmark; M A Peyrat; M Bonneville; J J Fournié; A Sjöstedt
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

8.  Interleukin 2 production in whole blood culture: a rapid test of immunity to Francisella tularensis.

Authors:  R Karttunen; J Ilonen; E Herva
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

9.  Development of Francisella tularensis antigen responses measured as T-lymphocyte proliferation and cytokine production (tumor necrosis factor alpha, gamma interferon, and interleukin-2 and -4) during human tularemia.

Authors:  H M Surcel; H Syrjälä; R Karttunen; S Tapaninaho; E Herva
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

10.  Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; A Galloway; G Sandstrom; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.